BR9106596A - PROCESS FOR THE TREATMENT OR PROPHYLAXIS OF AN INFECTION ASSOCIATED WITH RETROVIRUS, USE, PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF AN INFECTION ASSOCIATED WITH RETROVIRUS, AND, COMPOUND - Google Patents

PROCESS FOR THE TREATMENT OR PROPHYLAXIS OF AN INFECTION ASSOCIATED WITH RETROVIRUS, USE, PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF AN INFECTION ASSOCIATED WITH RETROVIRUS, AND, COMPOUND

Info

Publication number
BR9106596A
BR9106596A BR919106596A BR9106596A BR9106596A BR 9106596 A BR9106596 A BR 9106596A BR 919106596 A BR919106596 A BR 919106596A BR 9106596 A BR9106596 A BR 9106596A BR 9106596 A BR9106596 A BR 9106596A
Authority
BR
Brazil
Prior art keywords
retrovirus
prophylaxis
treatment
infection associated
compound
Prior art date
Application number
BR919106596A
Other languages
Portuguese (pt)
Inventor
Helmut Weigold
George Holan
Sebastian Mario Marcuccio
Christopher John Birch
Ian David Gust
Original Assignee
Commw Scient Ind Res Org
Fairfield Hospital Board
Macfarlane Burnet Centre For M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commw Scient Ind Res Org, Fairfield Hospital Board, Macfarlane Burnet Centre For M filed Critical Commw Scient Ind Res Org
Publication of BR9106596A publication Critical patent/BR9106596A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B25/00—Phosphorus; Compounds thereof
    • C01B25/16—Oxyacids of phosphorus; Salts thereof
    • C01B25/26—Phosphates
    • C01B25/45—Phosphates containing plural metal, or metal and ammonium
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B25/00—Phosphorus; Compounds thereof
    • C01B25/16—Oxyacids of phosphorus; Salts thereof
    • C01B25/26—Phosphates
    • C01B25/45—Phosphates containing plural metal, or metal and ammonium
    • C01B25/451—Phosphates containing plural metal, or metal and ammonium containing metal and ammonium

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR919106596A 1990-06-29 1991-06-28 PROCESS FOR THE TREATMENT OR PROPHYLAXIS OF AN INFECTION ASSOCIATED WITH RETROVIRUS, USE, PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF AN INFECTION ASSOCIATED WITH RETROVIRUS, AND, COMPOUND BR9106596A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPK091790 1990-06-29
PCT/AU1991/000280 WO1992000078A1 (en) 1990-06-29 1991-06-28 Antiviral agents containing heteropolytungstate

Publications (1)

Publication Number Publication Date
BR9106596A true BR9106596A (en) 1993-06-01

Family

ID=3774791

Family Applications (1)

Application Number Title Priority Date Filing Date
BR919106596A BR9106596A (en) 1990-06-29 1991-06-28 PROCESS FOR THE TREATMENT OR PROPHYLAXIS OF AN INFECTION ASSOCIATED WITH RETROVIRUS, USE, PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF AN INFECTION ASSOCIATED WITH RETROVIRUS, AND, COMPOUND

Country Status (10)

Country Link
EP (1) EP0536224A1 (en)
JP (1) JPH06501451A (en)
AU (1) AU647800B2 (en)
BR (1) BR9106596A (en)
CA (1) CA2086263A1 (en)
CZ (1) CZ396292A3 (en)
FI (1) FI925908A (en)
HU (1) HUT63332A (en)
NO (1) NO924966L (en)
WO (1) WO1992000078A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO820197A0 (en) * 1997-07-24 1997-08-14 Biomolecular Research Institute Limited Inorganic angiogenesis inhibitors
AUPO995297A0 (en) * 1997-10-24 1997-11-13 Starpharma Limited Inorganic antiviral compounds
GB9828020D0 (en) * 1998-12-18 1999-02-10 Bp Chem Int Ltd Synthesis of heteropolyacids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ230745A (en) * 1988-09-22 1991-02-26 Raymond Frederick Schinazi Composition for treatment of retrovirus infection comprising tingsten oxide-containing salts
GB8906189D0 (en) * 1989-03-17 1989-05-04 Johnson Matthey Plc Improvements in chemical compounds
GB9003430D0 (en) * 1990-02-15 1990-04-11 Johnson Matthey Plc Improvements in chemical compounds

Also Published As

Publication number Publication date
CZ396292A3 (en) 1994-01-19
EP0536224A1 (en) 1993-04-14
AU8006491A (en) 1992-01-23
AU647800B2 (en) 1994-03-31
JPH06501451A (en) 1994-02-17
NO924966L (en) 1993-02-17
FI925908A0 (en) 1992-12-28
CA2086263A1 (en) 1991-12-30
FI925908A (en) 1992-12-28
HUT63332A (en) 1993-08-30
WO1992000078A1 (en) 1992-01-09
NO924966D0 (en) 1992-12-22
HU9204137D0 (en) 1993-03-29

Similar Documents

Publication Publication Date Title
PT87259A (en) METHOD FOR PREPARING PHARMACEUTICAL COMPOSITIONS CONTAINING 17-CETOESTEROIDS PROPERATED FOR THE TREATMENT AND PROPHYLAXY OF RETROVIRAL INFECTIONS
PT98944A (en) PROCESS FOR THE PREPARATION OF ALTERED ANTIBODIES AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF INFECTIONS
BR9406566A (en) Pharmaceutical composition use of progesterone and / or 17 - - estradiol and process for the manufacture of a pharmaceutical preparation
BR9609780A (en) Compound use of a compound process for the treatment of pharmaceutical composition conditions processes for preparing a pharmaceutical composition and for preparing a compound
BR9100435A (en) COMPOUND, PHARMACEUTICAL COMPOSITION, USE, METHOD OF TREATING AN ANIMAL, PROCESSES FOR THE PREPARATION OF A COMPOUND AND PHARMACEUTICAL COMPOSITION
BR9100046A (en) AZAOXINDOLE DERIVATIVES, PHARMACEUTICAL COMPOSITION AND PROCESS FOR TREATING MAMMALS
BR9506581A (en) Compound pharmaceutical composition use of the process compound for the prophylaxis or treatment of a clinical condition in a manifer for example a human and for the preparation of a compound and intermediate compound
BR9502471A (en) Guanidine compound Process for preparing a guanidine compound Pharmaceutical composition Use of a guanidine compound Method for the prophylactic or therapeutic treatment of diseases and process for preparing a pharmaceutical composition
BR9005793A (en) COMPOSITION OF STABILIZED Aqueous Aqueous FLUORIDE AND PROCESS FOR PREPARATION OF THE SAME
PT84294B (en) PROCESS FOR THE PREPARATION OF REPLACED ANILINES AND COMPOSITION OF PHARMACEUTICAL COMPOSITIONS
PT90784A (en) Process for the preparation of a composition of materials for application on a body or limb
BR8805425A (en) ORGANOPOLYSILOXAN COMPOSITION AND USE OF THE SAME
ATE71840T1 (en) VIRUS INHIBITING NUCLEOSIDE MIXTURE.
ES2087279T3 (en) THE USE OF GIBERELINS FOR THE TREATMENT OF PROSTATITIS AND PSORIASIS.
BR8803768A (en) ODORANT COMPOSITION, PROCESS FOR THE PRODUCTION OF COMPOUNDS AND USE OF THESE COMPOUNDS
BR9509925A (en) Composition and use of the composition to prevent or treat HIV-1 infection
BR9106596A (en) PROCESS FOR THE TREATMENT OR PROPHYLAXIS OF AN INFECTION ASSOCIATED WITH RETROVIRUS, USE, PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF AN INFECTION ASSOCIATED WITH RETROVIRUS, AND, COMPOUND
BR9407530A (en) Peptide structure with multiple branches medicine use of a peptide structure with multiple branches method for the treatment of HIV infections process for the preparation of a peptide structure with multiple branches
EE03514B1 (en) A combination of compounds for the treatment of HIV infection or AIDS, its use and a pharmaceutical composition
BR8805426A (en) ORGANOPOLYSILOXAN COMPOSITION AND USE OF THE SAME
FI951759A0 (en) Process for the preparation of 2,2-difluorokethylsilyl-O, S-acetals and O, S-esters of alpha, alpha-difluoro-beta-silyloxy-1,3-dioxolane-4-propanoic acid
MX164619B (en) COMPOSITION FOR THE TREATMENT OF SKIN INJURIES
BR9205493A (en) Pharmaceutical composition and process for the manufacture of pharmaceutical composition
PT89742A (en) PREPARATION PROCEDURE OF 24R-CIMNOL AND ITS PHARMACEUTICAL COMPOSITIONS
BR9005081A (en) PHARMACEUTICAL AND VETERINARY COMPOSITION AND PROCESS FOR THE TREATMENT OR PREVENTION OF HELMINTHIASIS

Legal Events

Date Code Title Description
FC Decision: refusal
FC Decision: refusal